Search

Your search keyword '"Larsen, Nicholas A."' showing total 371 results

Search Constraints

Start Over You searched for: Author "Larsen, Nicholas A." Remove constraint Author: "Larsen, Nicholas A."
371 results on '"Larsen, Nicholas A."'

Search Results

1. Self-Supervised Learning for Time Series: A Review & Critique of FITS

2. Statistical Challenges in Online Controlled Experiments: A Review of A/B Testing Methodology

3. Dilations and information flow axioms in categorical probability

5. Anisotropic Forbush decrease of 24 March 2024: First look

6. An Operational Environment for Quantum Self-Testing

7. A Mathematical Framework for Causally Structured Dilations and its Relation to Quantum Self-Testing

9. Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors.

22. Regulatory role of cardiomyocyte metabolism via AMPK activation in modulating atrial structural, contractile, and electrical properties following atrial fibrillation

34. Antibody Catalysis of the Oxidation of Water

35. Statistical Challenges in Online Controlled Experiments: A Review of A/B Testing Methodology.

42. Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer

43. Association of Nicotine Cessation Time on the Incidence of Recurrent Incisional Hernia Repair and Postoperative Surgical Site Occurrences.

45. Figures S1-S6 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

46. Data from Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer

47. Data from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

48. Supplementary Figure from Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer

49. Tables S3-S4 from Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer

50. Supplementary Data from Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer

Catalog

Books, media, physical & digital resources